Skip to main content
Figure 4 | BMC Health Services Research

Figure 4

From: A multi-perspective cost-effectiveness analysis comparing rivaroxaban with enoxaparin sodium for thromboprophylaxis after total hip and knee replacement in the German healthcare setting

Figure 4

Effect of single model parameters on the results. Most influential parameters: Parameter 6, probability of a symptomatic deep vein thrombosis (DVT) event after prophylaxis with enoxaparin; Parameter 7, probability that an asymptomatic DVT becomes symptomatic; Parameter 17, prophylaxis costs with rivaroxaban.

Back to article page

BMC Health Services Research

ISSN: 1472-6963

Contact us